Market Place
Sourcing Support
AVITA Medical to Host Investor Webinar Briefing
08 Nov 2024 //
GLOBENEWSWIRE
AVITA Medical Reports Q3 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
AVITA Medical to Announce Third Quarter 2024 Financial Results
10 Oct 2024 //
GLOBENEWSWIRE
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Avita Medical To Participate In Lake Street Conference
10 Sep 2024 //
GLOBENEWSWIRE
AVITA Medical Reports Second Quarter Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
08 Aug 2024 //
GLOBENEWSWIRE
AVITA Medical Partners With Regenity To Expand Wound Care Portfolio
02 Aug 2024 //
PHARMABIZ
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
01 Aug 2024 //
GLOBENEWSWIRE
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
31 Jul 2024 //
GLOBENEWSWIRE
AVITA Medical to Announce Second Quarter 2024 Financial Results
11 Jul 2024 //
GLOBENEWSWIRE
Avita Medical Names Nicole Kelsey As Chief Legal And Compliance Officer
01 Jul 2024 //
GLOBENEWSWIRE
AVITA Medical Achieves Milestone with First Case Using RECELL GO
05 Jun 2024 //
GLOBENEWSWIRE
AVITA Medical Announces FDA Approval of RECELL GO
31 May 2024 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
16 May 2024 //
GLOBENEWSWIRE
AVITA Medical Reports First Quarter Financial Results
13 May 2024 //
GLOBENEWSWIRE
AVITA Medical To Announce Q1 2024 Results
15 Apr 2024 //
GLOBENEWSWIRE
AVITA Medical Updates Expected First Quarter 2024 Revenue
11 Apr 2024 //
GLOBENEWSWIRE
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
29 Feb 2024 //
GLOBENEWSWIRE
AVITA Submits Response to FDA, Resuming Review for RECELL GO PMA Supplement
29 Feb 2024 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
23 Feb 2024 //
GLOBENEWSWIRE
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
01 Feb 2024 //
GLOBENEWSWIRE
AVITA Medical Announces Preliminary 2023 Financial Highlights
10 Jan 2024 //
GLOBENEWSWIRE
AVITA Announces Exclusive Distribution Agreement with Stedical Scientific
10 Jan 2024 //
GLOBENEWSWIRE
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
04 Dec 2023 //
GLOBENEWSWIRE
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 //
GLOBENEWSWIRE
AVITA Medical Updates Full Year 2023 Guidance
20 Nov 2023 //
GLOBENEWSWIRE
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations
09 Nov 2023 //
GLOBENEWSWIRE
AVITA Medical Reports Third Quarter Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
AVITA Medical to Announce Third Quarter 2023 Financial Results
19 Oct 2023 //
GLOBENEWSWIRE
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights
18 Oct 2023 //
GLOBENEWSWIRE
AVITA Medical Receives Best Product Award at the American Association
25 Sep 2023 //
GLOBENEWSWIRE
AVITA Medical to Present at the Cantor Global Healthcare Conference
21 Sep 2023 //
GLOBENEWSWIRE
AVITA Medical to Participate in Upcoming Investor Conferences
06 Sep 2023 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
14 Aug 2023 //
GLOBENEWSWIRE
AVITA Medical Reports Second Quarter Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
AVITA Medical to Announce Second Quarter 2023 Financial Results
20 Jul 2023 //
GLOBENEWSWIRE
AVITA Medical Submits FDA PMA Supplement for RECELL GO
29 Jun 2023 //
GLOBENEWSWIRE
AVITA Medical Rejoins the Russell 3000 Index
26 Jun 2023 //
GLOBENEWSWIRE
AVITA Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo
16 Jun 2023 //
GLOBENEWSWIRE
AVITA Medical Announces Appointment of David O™Toole as Chief Financial Officer
15 Jun 2023 //
GLOBENEWSWIRE
AVITA Medical Announces FDA Approval of RECELL for Treatment of Skin Defects
07 Jun 2023 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
15 May 2023 //
GLOBENEWSWIRE
AVITA Reports First Quarter Financial Results and Affirms Full Year Guidance
11 May 2023 //
GLOBENEWSWIRE
AVITA Medical to Announce First Quarter 2023 Financial Results
20 Apr 2023 //
GLOBENEWSWIRE
Avita Medical Announces Update to Automation Device
13 Apr 2023 //
GLOBENEWSWIRE
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
23 Mar 2023 //
GLOBENEWSWIRE
Avita Medical Appoints New Non-Executive Member to the Board of Directors
16 Mar 2023 //
GLOBENEWSWIRE
AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference
02 Mar 2023 //
GLOBENEWSWIRE
AVITA Medical to Host Investor Webinar Briefing
27 Feb 2023 //
GLOBENEWSWIRE
AVITA Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
09 Feb 2023 //
GLOBENEWSWIRE
AVITA Medical Announces Fourth Quarter 2022 Earnings Conference Call
19 Jan 2023 //
GLOBENEWSWIRE
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
19 Dec 2022 //
GLOBENEWSWIRE
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication
12 Dec 2022 //
GLOBENEWSWIRE
AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
12 Dec 2022 //
GLOBENEWSWIRE
AVITA Medical to Present at the Piper Sandler 34th Annual Healthcare Conference
21 Nov 2022 //
GLOBENEWSWIRE
AVITA Medical Announces Achievement of Co-Primary Endpoints
09 Nov 2022 //
GLOBENEWSWIRE
